Previous Close | 2.9500 |
Open | 2.9300 |
Bid | 2.9300 x 40000 |
Ask | 2.9400 x 40000 |
Day's Range | 2.9200 - 2.9500 |
52 Week Range | 2.5100 - 6.4000 |
Volume | |
Avg. Volume | 392,548 |
Market Cap | 2.203B |
Beta (5Y Monthly) | 1.51 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3000 |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.67 |
Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2024 after market close on November 6, 2024.
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it has opened a new medical dispensary in Port St. Lucie, Florida. Curaleaf Port St Lucie, located at 1720 Southwest Gatlin Boulevard, Port St. Lucie, FL 34953, opens its doors to medical patients on October 3, 2024. The Company's newest dispensary brings its Florida store count to 65 locations, with 151 dispensaries total across the U.
Over the last 7 days, the Canadian market has remained flat, but it is up 13% over the past year with earnings expected to grow by 15% per annum. In this favorable environment, growth companies with high insider ownership can offer compelling opportunities as insiders' stakes often signal confidence in their business prospects.